Evidence map›Paper›PMID 36421341›Full record

ArticleCurrent oncology (Toronto, Ont.)2022

Feasibility Study and Clinical Impact of Incorporating Breast Tissue Density in High-Risk Breast Cancer Screening Assessment.

Alison Rusnak, Shawna Morrison, Erika Smith, Valerie Hastings, Kelly Anderson, Caitlin Aldridge, Sari Zelenietz, Karen Reddick, Sonia Regnier, Ellen Alie and 6 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current oncology (Toronto, Ont.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Alison RusnakInherited Cancer Program, Children's Hospital of Eastern Ontario, 401 Smyth Road, Ottawa, ON K1H 8L1, Canada.
Shawna MorrisonRegional Genetics Program, Children's Hospital of Eastern Ontario, Ottawa, ON K1H 8L1, Canada.
Erika SmithRegional Genetics Program, Children's Hospital of Eastern Ontario, Ottawa, ON K1H 8L1, Canada.
Valerie HastingsRegional Genetics Program, Children's Hospital of Eastern Ontario, Ottawa, ON K1H 8L1, Canada.
Kelly AndersonRegional Genetics Program, Children's Hospital of Eastern Ontario, Ottawa, ON K1H 8L1, Canada.
Caitlin AldridgeRegional Genetics Program, Children's Hospital of Eastern Ontario, Ottawa, ON K1H 8L1, Canada.ORCID 0000-0001-6267-0657
Sari ZelenietzRegional Genetics Program, Children's Hospital of Eastern Ontario, Ottawa, ON K1H 8L1, Canada.
Karen ReddickThe High-Risk OBSP Program Nurse Navigator, The Ottawa Hospital, Ottawa, ON K1H 8L6, Canada.
Sonia RegnierThe High-Risk OBSP Program Nurse Navigator, The Ottawa Hospital, Ottawa, ON K1H 8L6, Canada.
Ellen AliePreviously High-Risk OBSP Program Screening Manager, The Ottawa Hospital, Ottawa, ON K1H 8L6, Canada.
Nayaar IslamSchool of Epidemiology and Public Health, The Ottawa Hospital, University of Ottawa, Ottawa, ON K1N 6N5, Canada.ORCID 0000-0002-1159-7629
Rutaaba FasihDepartment of Radiology, The Ottawa Hospital, University of Ottawa, Ottawa, ON K1N 6N5, Canada.
Susan PeddleDepartment of Radiology, The Ottawa Hospital, University of Ottawa, Ottawa, ON K1N 6N5, Canada.
Erin CordeiroDepartment of Surgery, University of Ottawa, Ottawa, ON K1N 6N5, Canada.
Eva TomiakDepartment of Genetics, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, ON K1N 6N5, Canada.
Jean M SeelyDepartment of Radiology, The Ottawa Hospital, University of Ottawa, Ottawa, ON K1N 6N5, Canada.ORCID 0000-0003-0367-2219
Children's Hospital of Eastern Ontario · CAUniversity of Ottawa · CAOttawa Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast tissue density (BTD) is known to increase the risk of breast cancer but is not routinely used in the risk assessment of the population-based High-Risk Ontario Breast Screening Program (HROBSP). This prospective, IRB-approved study assessed the feasibility and impact of incorporating breast tissue density (BTD) into the risk assessment of women referred to HROBSP who were not genetic mutation carriers. All consecutive women aged 40-69 years who met criteria for HROBSP assessment and referred to Genetics from 1 December 2020 to 31 July 2021 had their lifetime risk calculated with and without BTD using Tyrer-Cuzick model version 8 (IBISv8) to gauge overall impact. McNemar's test was performed to compare eligibility with and without density. 140 women were referred, and 1 was excluded (

Indexed as

Breast NeoplasmsEarly Detection of CancerFeasibility StudiesFemaleHumansProspective StudiesRisk Assessmentbreast MRIbreast screeningdense breastshigh-risk breast screeningsupplemental breast screening

Identifiers

PMID36421341
PMCPMC9689826
OpenAlexW4309455313

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.